matrigel

commercially available product which consists of 60% laminin, 30% type 4 collagen, 5% nidogen, 3% heparin sulfate proteoglycan & 1% entactin; promotes neurite outgrowth in culture

Also Known As:

Matrigel

Pharmalogical Action Categories:

D001672 - Biocompatible Materials

Macromolecular Substances: 97
- Polymers: 13051
  - Biopolymers: 773
    - Collagen: 52417
      - matrigel: 3032
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Proteoglycans: 4798
      - matrigel: 3032
    - Membrane Glycoproteins: 2252
      - Laminin: 4721
        matrigel: 3032
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Laminin: 4721
        matrigel: 3032
  - Scleroproteins: 74
    - Extracellular Matrix Proteins: 3148
      - Collagen: 52417
        matrigel: 3032
      - Laminin: 4721
        matrigel: 3032
Pharmaceutical Preparations
- Drug Combinations: 5337
  - matrigel: 3032
Carbohydrates: 22023
- Polysaccharides: 15383
  - Proteoglycans: 4798
    - matrigel: 3032
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Proteoglycans: 4798
      - matrigel: 3032
    - Membrane Glycoproteins: 2252
      - Laminin: 4721
        matrigel: 3032

Shouming W Wang Selected Research

Shouming W Wang Research Topics

Disease

Drug/Important Bio-Agent (IBA)